Publications by Dr James Miller - ePrints

Browsing publications by Dr James Miller.

Newcastle Authors	Title	Year
Dr James Miller	Electrodiagnostic subtyping in Guillain–Barré syndrome patients in the International Guillain–Barré Outcome Study	2024
Dr James Miller	Role of the repeat expansion size in predicting age of onset and severity in RFC1 disease	2024
Dr James Miller	CSF Findings in Relation to Clinical Characteristics, Subtype, and Disease Course in Patients With Guillain-Barré Syndrome	2023
Dr James Miller	Rituximab for myasthenia gravis	2023
Dr James Miller	Two emerging phenotypes of atypical inclusion body myositis: illustrative cases	2023
Dr James Miller	An International Perspective on Preceding Infections in Guillain-Barré Syndrome: The IGOS-1000 Cohort	2022
Dr Kirstie Anderson Dr Naomi Warren Dr Duddy Duddy Dr James Miller	Delivering an advice and guidance service in neurology	2022
Kundan Iqbal Dr James Miller Dr Horn Lai Dr Ben Thompson	High median nerve lesion secondary to severe giant cell arteritis	2022
Dr James Miller	Predicting Outcome in Guillain-Barré Syndrome International Validation of the Modified Erasmus GBS Outcome Score	2022
Jane Newman Dr James Miller Professor Djordje Jakovljevic Professor Grainne Gorman Emeritus Professor Doug Turnbull et al.	Interventions for promoting physical activity in people with neuromuscular disease	2021
Dr James Miller	Long-term strength and functional status in inclusion body myositis and identification of trajectory subgroups	2020
Dr Katherine Johnson Dr Ana Topf Dr Marta Bertoli Lauren Charlotte Phillips Phillips Dr James Miller et al.	Extending the clinical and mutational spectrum of TRIM32-related myopathies in a non-Hutterite population	2019
Dr Bridget Griffiths Dr James Miller	Increasing incidence of adult idiopathic inflammatory myopathies in the City of Salford, UK: A 10-year epidemiological study	2018
Dr Boglárka Bánsági Professor Mark Baker Matt Jennings Professor Roger Whittaker Dr Jennifer Duff et al.	Multifocal demyelinating motor neuropathy and hamartoma syndrome associated with a de novo PTEN mutation	2018
Dr James Miller	Regional variation of Guillain-Barré syndrome	2018
Dr James Miller Professor Michael Hanna	Cytosolic 5′-nucleotidase 1A autoantibody profile and clinical characteristics in inclusion body myositis	2017
Dr Boglárka Bánsági Dr Helen Griffin Professor Roger Whittaker Dr Teresinha Evangelista Dr James Miller et al.	Genetic heterogeneity of motor neuropathies	2017
Dr Karolina Rygiel Dr Helen Tuppen Dr John Grady Dr Amy Vincent Dr Amy Reeve et al.	Complex mitochondrial DNA rearrangements in individual cells from patients with sporadic inclusion body myositis	2016
Maria Wesolowska Professor Grainne Gorman Dr Charlotte Alston Aleksandra Pajak Dr Angela Pyle et al.	Adult Onset Leigh Syndrome in the Intensive Care Setting: A Novel Presentation of a C12orf65 Related Mitochondrial Disease	2015
Dr Michael Keogh Dr Angela Pyle Daniyal Daud Dr Helen Griffin Dr Konstantinos Douroudis et al.	Clinical heterogeneity of primary familial brain calcification due to a novel mutation in PDGFB	2015
Dr James Miller	Treatment for inclusion body myositis	2015
Professor Fai Ng Dr James Miller	Idiopathic axonal neuropathy and primary Sjögren's syndrome	2014
Dr Karolina Rygiel Dr James Miller Dr John Grady Professor Robert Taylor Emeritus Professor Doug Turnbull et al.	Mitochondrial and inflammatory changes in sporadic inclusion body myositis	2014
Professor Roger Whittaker Professor Patrick Chinnery Dr James Miller	Teaching Video NeuroImages: Muscle cramps and a raised creatine kinase	2014
Katherine Jones Dr Roger Whittaker Dr James Miller Professor Djordje Jakovljevic Emeritus Professor Doug Turnbull et al.	Can high intensity interval training improve functional capacity and clinical symptoms in inflammatory and mitochondrial myopathies?	2013
Katherine Jones Professor Roger Whittaker Dr James Miller Professor Djordje Jakovljevic Emeritus Professor Doug Turnbull et al.	The Effects of High Intensity Interval Training on Clinical Symptoms and Functional Capacity in Adults with Neuromuscular Disease	2013
Dr Stephan Jaiser Dr Karen Fisher Dr Boubker Zaaimi Dr James Miller Professor Patrick Chinnery et al.	15-30 HZ Intermuscular Coherence as a Potential Biomarker of Upper Motor Neuron Dysfunction in Motor Neuron Disease.	2012
Dr Debbie Hicks Dr Anna Sarkozy Dr Nuria Muelas Gomez Professor Gavin Hudson Professor Patrick Chinnery et al.	A founder mutation in Anoctamin 5 is a major cause of limb girdle muscular dystrophy	2011
Dr Debbie Hicks Dr Anna Sarkozy Dr Nuria Muelas Gomez Professor Gavin Hudson Professor Patrick Chinnery et al.	A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy	2011
Professor Patrick Chinnery Dr Matthew Jackson Dr Patrick Yu Wai Man Professor Grainne Gorman Michelle Baker et al.	Mutations in OPA1 expand the clinical phenotype of mitochondrial disease	2010
Dr Will Sedley Dr James Miller Dr Thomas Kelly	Long-term Sleep Disturbance Following Recovery From Anti-NMDAR Encephalitis	2009
Dr Ben Thompson Dr James Miller Professor John Isaacs	Alemtuzumab (Campath-1H) for treatment of refractory polymyositis	2008
Dr James Miller	Markedly different clinical course in a mother and son with Inclusion Body Myositis and different MHC haplotypes	2006
Dr James Miller	Statins for sepsis: a cautionary note	2006
Dr James Miller	Statins - challenges and provocations	2005